Page last updated: 2024-10-26

doxazosin and Anterior Choroidal Artery Infarction

doxazosin has been researched along with Anterior Choroidal Artery Infarction in 1 studies

Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.

Research Excerpts

ExcerptRelevanceReference
" The purpose of this study was to evaluate the effect of the alpha(1)-adrenoceptor antagonist, doxazosin mesilate, on cerebral blood flow (CBF) and flow velocity in the common carotid artery in patients with hypertension and chronic cerebral infarction."7.75The effect of doxazosin mesilate on cerebral blood flow in patients with hypertension and chronic cerebral infarction. ( Katayama, Y; Usuda, K, 2009)
" The purpose of this study was to evaluate the effect of the alpha(1)-adrenoceptor antagonist, doxazosin mesilate, on cerebral blood flow (CBF) and flow velocity in the common carotid artery in patients with hypertension and chronic cerebral infarction."3.75The effect of doxazosin mesilate on cerebral blood flow in patients with hypertension and chronic cerebral infarction. ( Katayama, Y; Usuda, K, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Usuda, K1
Katayama, Y1

Other Studies

1 other study available for doxazosin and Anterior Choroidal Artery Infarction

ArticleYear
The effect of doxazosin mesilate on cerebral blood flow in patients with hypertension and chronic cerebral infarction.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2009, Volume: 76, Issue:3

    Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Ca

2009